Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Biomarin Pharmaceutical Inc

NASDAQ: BMRN · Life Sciences · 7 alerts · CIK 1048477

Share price
$57.99Close, Nov 16
Market cap
$11.2B
Shares outstanding
193.69MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Biomarin Pharmaceutical Inc filings on SEC EDGAR ↗

8:32 AM ET 8-K
Other 8-K Filing

Biomarin Pharmaceutical Other 8-K Filing

BioMarin Pharmaceutical Inc. announced its decision to discontinue the clinical development of VOXZOGO for children with Noonan syndrome. The company cited study feasibility and the current treatment landscape as reasons for the move, noting the decision was not related to safety or efficacy.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.